Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Netherlands Brief.
Press releases published on June 2, 2025
PayToMe.co Joins NVIDIA Inception to Tackle $46B SMB Finance Problem With AI
EIN Presswire
·
June 2, 2025
NVIDIA Inception supports PayToMe.co’s mission to empower 400M SMBs with real-time payments, compliance automation, and global AI infrastructure. SAN FRANCISCO, CA, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- 🚀 PayToMe.co, an award-winning AI- …
New Documentary Highlights Advances in Headache Research and Offers Hope to Billions
EIN Presswire
·
June 2, 2025
The International Headache Society (IHS) is set to launch the documentary series Headed for the Future at the start of Migraine Awareness Month. LONDON, UNITED KINGDOM, June 2, 2025 /EINPresswire.com/ -- The International Headache Society (IHS) is set …
vBoxx Launches vBoxxOne: A Unified, Secure Platform for European Businesses
EIN Presswire
·
June 2, 2025
New app empowers organizations with customized digital services while upholding European data sovereignty THE HAGUE, NETHERLANDS, June 2, 2025 /EINPresswire.com/ -- vBoxx today announced the launch of vBoxxOne, a new all-in-one application that brings …
Sébastien Jacquet Appointed Chief Quality Officer
GlobeNewswire
·
June 2, 2025
Sébastien Jacquet Appointed Chief Quality Officer AMSTERDAM, June 2, 2025 – Stellantis N.V. today announced the appointment of Sébastien Jacquet as Chief Quality Officer, effective immediately. He succeeds Antonio Filosa, who has been appointed to be the …
ASML reports transactions under its current share buyback program
GlobeNewswire
·
June 2, 2025
ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. Date Total repurchased shares Weighted average …
Pharvaris Presents Data Supporting Ongoing Clinical Development of Deucrictibant in Bradykinin-Mediated Angioedema
GlobeNewswire
·
June 2, 2025
Deucrictibant data shows single-dose durability without symptom reoccurrence in the majority of HAE attacks treated First-ever bradykinin B2 receptor mechanism-on-mechanism prophylactic/on-demand data supports potential for deucrictibant portfolio …